Skip to main content
. 2011 Jan;13(1):93–99. doi: 10.1016/j.jmoldx.2010.11.011

Figure 2.

Figure 2

Results of MSH2 hypermethylation test by methylation-specific PCR and fragment length analysis. A: Shows the results of the ABI-based fragment analysis for methylation-specific primers in region 1 of the MSH2 promoter. MSH2 hypermethylation can be seen in tumor and normal tissue in a case with a EPCAM/TACSTD1 deletion. In contrast, the negative control case (loss of MLH1 expression) does not show MSH2 methylation. B: Shows similar data for region 3 of the MSH2 promoter.